240 related articles for article (PubMed ID: 34699318)
1. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
[TBL] [Abstract][Full Text] [Related]
2. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
Peng H; Pan X; Su Q; Zhu LS; Ma GD
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
[TBL] [Abstract][Full Text] [Related]
3. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
[TBL] [Abstract][Full Text] [Related]
4. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
5. Expression of hippo pathway in colorectal cancer.
Liang K; Zhou G; Zhang Q; Li J; Zhang C
Saudi J Gastroenterol; 2014; 20(3):188-94. PubMed ID: 24976283
[TBL] [Abstract][Full Text] [Related]
6. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
Luo SY; Sit KY; Sihoe AD; Suen WS; Au WK; Tang X; Ma ES; Chan WK; Wistuba II; Minna JD; Tsao GS; Lam DC
Lung Cancer; 2014 Aug; 85(2):282-92. PubMed ID: 24976335
[TBL] [Abstract][Full Text] [Related]
7. Matrine promotes apoptosis in SW480 colorectal cancer cells via elevating MIEF1-related mitochondrial division in a manner dependent on LATS2-Hippo pathway.
Zhang Y; Wang M; Xu X; Liu Y; Xiao C
J Cell Physiol; 2019 Dec; 234(12):22731-22741. PubMed ID: 31119752
[TBL] [Abstract][Full Text] [Related]
8. The E3 ubiquitin ligase SCF (FBXW10)-mediated LATS2 degradation regulates angiogenesis and liver metastasis in colorectal cancer.
Zhang ZY; Sun JH; Liang MJ; Wang XP; Guan J; Zhou ZQ
Int J Biochem Cell Biol; 2023 May; 158():106408. PubMed ID: 36990424
[TBL] [Abstract][Full Text] [Related]
9. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance and biological function of large tumour suppressor 2 in hepatocellular carcinoma.
Liang R; Lin Y; Yuan CL; Liu ZH; Li YQ; Luo XL; Ye JZ; Ye HH
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28247446
[TBL] [Abstract][Full Text] [Related]
11. High expression of meningioma 1 is correlated with reduced survival rates in colorectal cancer patients.
Ho YJ; Liu FC; Chang J; Shi B; Yeh KT; Lin YM; Lu JW
Acta Histochem; 2019 Jul; 121(5):628-637. PubMed ID: 31133374
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylated LATS2 gene with decreased expression in female breast cancer: A case control study from North India.
Sadaf ; Habib M; Khan MA; Najm MZ; Mallick MN; Sunita K; Shukla NK; Deo SVS; Husain SA
Gene; 2018 Nov; 676():156-163. PubMed ID: 30010037
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA DILC as a potentially useful biomarker for the diagnosis and prognosis of colorectal cancer.
Li QG; Xu XQ; Zhou DY; Jia ZB; Yu BF; Xu FG; Zhang L
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3320-3325. PubMed ID: 31081085
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
[TBL] [Abstract][Full Text] [Related]
15. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
[TBL] [Abstract][Full Text] [Related]
16. LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer.
Du YL; Liang Y; Shi GQ; Cao Y; Qiu J; Yuan L; Yong Z; Liu L; Li J
Exp Cell Res; 2020 Oct; 395(1):112176. PubMed ID: 32682784
[TBL] [Abstract][Full Text] [Related]
17. A specific tRNA half, 5'tiRNA-His-GTG, responds to hypoxia via the HIF1α/ANG axis and promotes colorectal cancer progression by regulating LATS2.
Tao EW; Wang HL; Cheng WY; Liu QQ; Chen YX; Gao QY
J Exp Clin Cancer Res; 2021 Feb; 40(1):67. PubMed ID: 33588913
[TBL] [Abstract][Full Text] [Related]
18. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Yuan J; Xie A; Cao Q; Li X; Chen J
Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
[TBL] [Abstract][Full Text] [Related]
20. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
